EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 3.0

Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors

Yuying Lin, Duo Qian, Bingxin Jiang, Shanshan Zhang, Tingting Li

Journal of Multidisciplinary Healthcare · 2026-10 · Volume 19 · 1-9

DOI: 10.2147/jmdh.s601651 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Multidisciplinary Healthcare, 2026-10. Verfasst von Yuying Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the incidence of and factors associated with frailty in hepatocellular carcinoma (HCC) patients after transarterial chemoembolization (TACE), with the objective to inform future personalized managements.

Methods

In this cross-sectional study conducted from January to October 2025, HCC patients undergoing TACE at a tertiary hospital in Suzhou were selected by convenience sampling and completed a general information questionnaire. The Fried frailty phenotype, Nutritional Risk Screening 2002 tool, and Barthel Index for activities of daily living were comprehensively evaluated between postoperative days 1 and 4 following TACE. Factors associated with frailty after TACE were identified via univariate and multivariate logistic regression analyses.

Results

Among the 312 included patients, 87 (27.9%) patients and 225 (72.1%) patients were in the frailty and non-frailty groups, respectively. Univariate analysis revealed statistically significant differences in age, sex, nutritional risk, Barthel Index, systemic immune-inflammatory index (SII), and hemoglobin level between the two groups (P

Schlagwörter

Stichwörter der Autor:innen

frailtyhepatocellular carcinomanursing caretransarterial chemoembolization

Autor:innen und Institutionen

  • Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, People's Republic of China.

Zitieren

APA

Lin, Y., Qian, D., Jiang, B., Zhang, S., & Li, T. (2026). Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors. Journal of Multidisciplinary Healthcare, Volume 19, 1-9. https://doi.org/10.2147/jmdh.s601651

Vancouver

Lin Y, Qian D, Jiang B, Zhang S, Li T. Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors. Journal of Multidisciplinary Healthcare. 2026;Volume 19:1-9. doi:10.2147/jmdh.s601651

BibTeX
@article{Lin2026,
  author = {Lin, Yuying and Qian, Duo and Jiang, Bingxin and Zhang, Shanshan and Li, Tingting},
  title = {Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors},
  journal = {Journal of Multidisciplinary Healthcare},
  year = {2026},
  volume = {Volume 19},
  pages = {1--9},
  doi = {10.2147/jmdh.s601651}
}
Kostenlos starten →